Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021Masayuki Teramoto, Shahzaib Ahmad, Hazim Ababneh et al.|The Lancet|2024Cited by 931
Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021Masayuki Teramoto, Muayyad Ahmad, Emmanuela Gakidou et al.|The Lancet|2025Cited by 801
Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021Masayuki Teramoto, Noah Ahmad, George Patton et al.|The Lancet|2025Cited by 316
Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023Masayuki Teramoto, Mohammed Z. Allouh, Qorinah Estiningtyas Sakilah Adnani et al.|The Lancet|2025Cited by 153
Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021Masayuki Teramoto, Salah Al Awaidy, Marissa B Reitsma et al.|The Lancet Public Health|2024Cited by 125